Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations

1 Feb 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal and Polyclonal Antibodies Research
Share to RNA and protein synthesis mechanisms
Share to Viral Infectious Diseases and Gene Expression in Insects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29392566
DOI: 10.1007/s40259-018-0261-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and ConsiderationsPMID 29392566Read ↗

A critical analysis of codon optimization in human therapeuticsSemantic proximity Read ↗

Codon-optimization in gene therapy: promises, prospects and challengesSemantic proximity Read ↗

Critical reflections on synthetic gene design for recombinant protein expressionSemantic proximity Read ↗

Evaluating codon optimization strategies for mammalian glycoprotein production with an open-source expression vectorSemantic proximity Read ↗

A general evidence-based sequence variant control limit for recombinant therapeutic protein developmentSemantic proximity Read ↗

Genetic optimization of recombinant glycoprotein production by mammalian cellsSemantic proximity Read ↗

Downregulating Viral Gene Expression: Codon Usage Bias Manipulation for the Generation of Novel Influenza A Virus VaccinesSemantic proximity Read ↗

Affordable mRNA Novel Proteins, Recombinant Protein Conversions and “Biosimilars”—Advice to Developers and Regulatory AgenciesSemantic proximity Read ↗

A concise guide to choosing suitable gene expression systems for recombinant protein productionSemantic proximity Read ↗

Recombinant proteins for therapySemantic proximity Read ↗

Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.Semantic proximity Read ↗

Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.